These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Antigenicity of cholera toxoid in humans. Author: Germanier R, Fürer E, Varallyay S, Inderbitzin TM. Journal: J Infect Dis; 1977 Apr; 135(4):512-6. PubMed ID: 856918. Abstract: A cholera toxoid was produced by heating of a purified cholera toxin and treatment of the resulting toxoid procholeragenoid with a formaldehyde solution. When given subcutaneously and intramuscularly to volunteers in doses of 3-100 microng, the toxoid produced no noteworthy side effects, but the injections produced a dose-dependent rise in level of toxin-neutralizing antibodies in serum. Administration of toxoid in combination with whole-cell vaccine induced antitoxin levels that seemed to be higher than those induced by toxoid alone, but statistical analysis revealed a significant difference only between titers after administration of 10 microng of toxoid alone and those after administration of 10 microng of toxoid in combination with whole-cell vaccine.[Abstract] [Full Text] [Related] [New Search]